Arnd Christ
Director of Finance/CFO presso IMMATICS N.V.
Patrimonio netto: 2 M $ in data 31/03/2024
Provenienza dei contatti di primo grado di Arnd Christ
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 23 | |
Hoechst AG
 Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany.
13
| Extinct | Chemicals: Major Diversified | 13 |
11
| Public Company | Biotechnology | 11 |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
| Subsidiary | Medical/Nursing Services | 6 | |
| Public Company | Biotechnology | 5 | |
| Public Company | Containers/Packaging | 5 | |
| Public Company | Biotechnology | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Arnd Christ tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| IBM | Information Technology Services | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| FRESENIUS SE & CO. KGAA | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| ANSYS, INC. | Packaged Software | Director/Board Member Director/Board Member | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
HNA Holdings, Inc.
 HNA Holdings, Inc. Chemicals: SpecialtyProcess Industries Part of Celanese Corp., HNA Holdings, Inc. is a manufacturer of inorganic dye and pigment. The private company is based in Summit, NJ. | Chemicals: Specialty | Chairman Corporate Officer/Principal | |
| BAYER AG | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Director/Board Member | |
Ariba, Inc.
 Ariba, Inc. Packaged SoftwareTechnology Services Ariba, Inc. provides collaborative business commerce solutions. Its solutions include spend and supplier management, spend analysis, financial supply chain management, sourcing, contract management, supply chain collaboration and invoice management. The company was founded by Keith J. Krach, Robert J. Desantis, Paul Hegarty, Edward P. Kinsey, Robert D. Lent, Boris Putanec and Paul C. M. Touw in 1996 and is headquartered in Sunnyvale, CA. | Packaged Software | Director of Finance/CFO Chief Executive Officer Director of Finance/CFO | |
| 2INVEST AG | Financial Conglomerates | Chairman Director/Board Member Director/Board Member | |
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Masters Business Admin | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| MORPHOSYS AG | Biotechnology | Director/Board Member Human Resources Officer Corporate Officer/Principal Director of Finance/CFO | |
| University of Freiburg | College/University | Graduate Degree Graduate Degree | |
| HBM HEALTHCARE INVESTMENTS AG | Investment Managers | Founder Director/Board Member | |
| The University of Chicago | College/University | Masters Business Admin Undergraduate Degree | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Corporate Officer/Principal | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director/Board Member Chairman Human Resources Officer Director/Board Member | |
| Eberhard Karls Universität Tübingen | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Graduate Degree Director/Board Member Doctorate Degree | |
| Technical University of Berlin | College/University | Doctorate Degree Undergraduate Degree | |
| The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH
 IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH Investment ManagersFinance Beteiligungsgesellschaft Sachsen-Anhalt mbH is a private equity/ venture capital firm founded in 1996. The firm is headquartered in Magedeburg. | Investment Managers | Chief Executive Officer Corporate Officer/Principal | |
| University of Regensburg | College/University | Undergraduate Degree Undergraduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| IVERIC BIO, INC. | Pharmaceuticals: Generic | Director of Finance/CFO Corporate Officer/Principal | |
InflaRx GmbH
 InflaRx GmbH BiotechnologyHealth Technology InflaRx GmbH operates as a biotech company which develops new therapeutics in the field of inflammation. It focuses on the general area of inflammation including indications such as SIRS and SEPSIS by applying innovative therapeutics in order to prevent organ dysfunction or limit progression into organ failure. The firm's complement system is activated and produces large amounts of products including complement 5a (C5a), C3a, C4a and membrane-attack complex (MAC). The company was founded in 2007 by Niels Riedemann and Renfeng Guo and is headquartered in Jena, Germany. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Chairman Director/Board Member | |
European Society for Medical Oncology
 European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Investment Managers | Private Equity Investor Founder Chief Executive Officer | |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Febit, Inc. | Director/Board Member Chairman | ||
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Investor Relations Contact General Counsel | |
Sitecore Danmark A/S
 Sitecore Danmark A/S Packaged SoftwareTechnology Services Sitecore Danmark A/S develops software that allows marketers to take control of the customer experience. It offers platform for managing customer experience through combination of web content management and customer intelligence. The firm provides search engine optimization, social network integration, customizable forms, cloud computing, predictive analytics, and marketing automation across web and mobile platforms. The company was founded by Thomas Albert, Peter Christensen, Ole Thrane, Lars Fløe Nielsen, Michael Seifert, and Jakob Christensen in 2001 and is headquartered in Copenhagen, Denmark. | Packaged Software | Director/Board Member Director of Finance/CFO | |
| dievini Verwaltungs GmbH | Chief Executive Officer Chief Executive Officer Chief Executive Officer | ||
Molecular Health GmbH
 Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The private company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Miscellaneous Commercial Services | Chief Executive Officer Chairman Director/Board Member | |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Chairman Director/Board Member Director/Board Member | |
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Medical Specialties | Chairman Director/Board Member | |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Biotechnology | Chairman Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Founder Director/Board Member Director/Board Member Director/Board Member Founder Chief Tech/Sci/R&D Officer |
Statistiche
Distribuzione geografica
| Germania | 28 |
| Stati Uniti | 16 |
| Svizzera | 5 |
| Regno Unito | 2 |
| Belgio | 2 |
Settori
| Health Technology | 20 |
| Consumer Services | 14 |
| Technology Services | 6 |
| Finance | 5 |
| Commercial Services | 5 |
Posizioni
| Director/Board Member | 294 |
| Corporate Officer/Principal | 166 |
| Chairman | 107 |
| Chief Executive Officer | 80 |
| Independent Dir/Board Member | 69 |
Contatti più connessi
| Insiders | |
|---|---|
| Christof Hettich | 40 |
| Friedrich von Bohlen und Halbach | 36 |
| Eliot Forster | 35 |
| Erich Maximilian Platzer | 31 |
| Utz-Hellmuth Felcht | 26 |
| Peter Chambré | 23 |
| Mathias Hothum | 19 |
| Joe Manko | 18 |
| Jürgen Dormann | 17 |
| Harald F. Stock | 17 |
| Adam Stone | 17 |
| Uta Kemmerich-Keil | 16 |
| Carsten Reinhardt | 16 |
| Michael Atieh | 16 |
| Dinnies Johannes von der Osten | 16 |
- Borsa valori
- Insiders
- Arnd Christ
- Connessioni Società
